The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 52,304 | 52,275 | 49,844 | 48,580 | 0 |
| Cost of Goods | 43,971 | 40,852 | 38,954 | 38,378 | N/A |
| Gross Profit | 8,333 | 11,423 | 10,890 | 10,202 | N/A |
| Operating Expenses | 50,136 | 14,432 | 12,960 | 12,333 | 195,231 |
| Operating Income | -40,832 | -2,157 | -1,116 | -1,753 | -7,716 |
| Interest Expense | 60 | 78 | 81 | 101 | 0 |
| Other Income | 28,268 | 54 | 5,182 | 1,076 | -1,299 |
| Pre-tax Income | -12,624 | -2,181 | 3,985 | -778 | -9,015 |
| Income Tax | -2,468 | 799 | 780 | 218 | -506 |
| Net Income Continuous | -10,156 | -2,980 | 3,205 | -996 | -8,510 |
| Net Income | $-10,156 | $-2,980 | $3,205 | $-996 | $-8,510 |
| EPS Basic Total Ops | -0.14 | -0.05 | 0.05 | -0.02 | 0.45 |
| EPS Basic Continuous Ops | -0.15 | -0.05 | 0.05 | -0.02 | 0.78 |
| EPS Diluted Total Ops | -0.14 | -0.05 | 0.05 | -0.02 | 0.45 |
| EPS Diluted Continuous Ops | -0.15 | -0.05 | 0.05 | -0.02 | 0.78 |
| EBITDA(a) | $-39,912 | $-1,289 | $-305 | $-958 | $-195,231 |